Recipharm appoints new Directors, Business Management to further strengthen European sales drive
29th April: Recipharm, the leading contract development and manufacturing organisation, is pleased to announce the appointment of two new Directors of Business Management. These appointments form part of Recipharm’s strategic drive to increase the volume of its business and revenues in key European markets.
Henning Neubauer has joined the Business Management team at Recipharm, taking on the position of Business Director for Northern Germany and the Netherlands. In parallel, Antonio Lopez also joins the team in the role of Business Director for Spain and Southern France.
Previously, Neubauer was Chief Operating Officer (COO). at a German start-up company in Hamburg dealing with generic products, OTC and Rx. Prior to that, he worked for more than ten years at Haupt Pharma as Head of Customer Service and Sales, responsible for leading the Customer Service Team and key account management. He has a degree and Diploma in Marketing from the Open University of Bad Harzburg.
Antonio Lopez, has previous experiences in Business Development and partnering, logistics, compliance and regulatory activities in the role as VP of Operations in Flavine, a US trading company involved in generics APIs and finished dosage forms. Prior to this, he worked for more than 20 years at the Spanish pharmaceutical company Grupo Uriach. Antonio graduated with a Pharmacist degree from the University of Barcelona and holds a Masters in Business Administration from Barcelona’s Esade Business School.
As a further initiative to bolster the Business Management organization, Åsa Wilander joined the team in mid-January in the new role of Key Account Director for the Nordic region. In this role, Åsa will be responsible for coordinating customer management and commercial aspects, as well as developing relationships with a selected number of customers. Åsa has been with Recipharm since 2007. To date, she has been working as General Manager of the Höganäs facility and led a significant expansion of the company. She has some 30 years experience of the pharmaceutical industry including the leadership of a contract manufacturing supply team at Pfizer.
Commenting on the new appointments, Kenth Berg, VP Business Management Recipharm, stated: “I am very pleased to have such talent join our business management structure. Europe is one of our key markets and we look forward to utilising the respective skills and expertise of Henning and Antonio to further enhance our European sales drive in Germany, the Netherlands and Spain.”
He continued: “Indeed post our recent IPO, this is an exciting time to plan ahead and expand our revenues and turnover across our international operations of which Europe is a highly important component”.
Contact information
Recipharm – Kenth Berg, Vice Presidens Business Management, Contact: +46 8 602 52 16
For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on: E-mail: t.jervis@defacto.com or a.heeley@defacto.com
Tel: +44 (0) 207 861 3019/3043
About Recipharm
Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry based in Sweden employing some 1,500 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and pharmaceutical product development. Recipharm currently manufactures more than 200 different products to both Big Pharma and smaller research- and development companies. Recipharm’s turnover is approximately SEK 2.1 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany and Spain and is headquartered in Jordbro.
Tags:
